Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -189,291 | -130,657 | -163,661 | -78,348 | -76,970 |
| Depreciation Amortization | 22,150 | 16,660 | 10,962 | 5,319 | 17,787 |
| Accounts receivable | -11,973 | 2,520 | 1,903 | -30,085 | 35,229 |
| Accounts payable and accrued liabilities | 17,731 | 1,440 | -1,060 | -3,223 | -3,051 |
| Other Working Capital | 174,630 | 150,111 | 208,183 | -3,213 | -85,659 |
| Other Operating Activity | 68,355 | 48,756 | 33,852 | 50,064 | 33,959 |
| Operating Cash Flow | $81,602 | $88,830 | $90,179 | $-59,486 | $-78,705 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,414 | 10,568 | N/A | N/A | -411,299 |
| PPE Investments | -3,994 | -1,604 | -1,185 | -459 | -5,755 |
| Purchase Of Investment | -3,896 | -2,145 | -1,457 | -38 | N/A |
| Sale Of Investment | 457,963 | 301,900 | 212,506 | 56,506 | 537,072 |
| Investing Cash Flow | $452,487 | $308,719 | $209,864 | $56,009 | $120,018 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -13,023 | -9,556 | -6,193 | -2,915 | -12,328 |
| Common Stock Issued | 37,829 | 26,247 | 16,510 | 7,004 | 20,778 |
| Other Financing Activity | -11,463 | -9,007 | -6,858 | -5,279 | -12,750 |
| Financing Cash Flow | $13,343 | $7,684 | $3,459 | $-1,190 | $-4,300 |
| Exchange Rate Effect | 4,695 | 969 | -499 | -39 | -5 |
| Beginning Cash Position | 126,266 | 126,266 | 126,266 | 126,266 | 89,258 |
| End Cash Position | 678,393 | 532,468 | 429,269 | 121,560 | 126,266 |
| Net Cash Flow | $552,127 | $406,202 | $303,003 | $-4,706 | $37,008 |
| Free Cash Flow | |||||
| Operating Cash Flow | 81,602 | 88,830 | 90,179 | -59,486 | -78,705 |
| Capital Expenditure | -3,994 | -1,604 | -1,185 | -459 | -5,762 |
| Free Cash Flow | 77,608 | 87,226 | 88,994 | -59,945 | -84,467 |